Form 4: Vita Coco Company Executive Charles van Es Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Charles van Es, Chief Sales Officer of Vita Coco Company, reports acquisition and disposition of common stock and stock options.

Summary

  • Charles van Es, Chief Sales Officer of Vita Coco Company, filed a Form 4 detailing changes in beneficial ownership.
  • On March 4, 2025, van Es acquired 5,096 shares of common stock and disposed of 1,063 shares to cover tax withholding obligations.
  • Following these transactions, van Es directly owns 94,723 shares of common stock.
  • Van Es was also granted 13,218 non-qualified stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
  • The reported transactions also include holdings of other non-qualified stock options with varying exercise prices and vesting schedules.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an officer. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership by a company officer.

Key Dates

DateDescription
03/04/2025Date of stock acquisition, disposition, and stock option grant.
03/06/2025Date of Form 4 filing.
03/04/2035Expiration date of a portion of the non-qualified stock options granted on 03/04/2025.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.